Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apyx Medical (APYX) Depreciation & Amortization (CF) (2016 - 2026)

Apyx Medical filings provide 15 years of Depreciation & Amortization (CF) readings, the most recent being $221000.0 for Q4 2025.

  • On a quarterly basis, Depreciation & Amortization (CF) rose 55.63% to $221000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $655000.0, a 9.35% increase, with the full-year FY2025 number at $655000.0, up 9.35% from a year prior.
  • Depreciation & Amortization (CF) hit $221000.0 in Q4 2025 for Apyx Medical, up from $164000.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $247000.0 in Q2 2022 to a low of $132000.0 in Q2 2025.
  • Median Depreciation & Amortization (CF) over the past 5 years was $194000.0 (2022), compared with a mean of $186950.0.
  • Biggest five-year swings in Depreciation & Amortization (CF): plummeted 38.87% in 2023 and later skyrocketed 55.63% in 2025.
  • Apyx Medical's Depreciation & Amortization (CF) stood at $229000.0 in 2021, then fell by 11.79% to $202000.0 in 2022, then dropped by 24.75% to $152000.0 in 2023, then dropped by 6.58% to $142000.0 in 2024, then skyrocketed by 55.63% to $221000.0 in 2025.
  • The last three reported values for Depreciation & Amortization (CF) were $221000.0 (Q4 2025), $164000.0 (Q3 2025), and $132000.0 (Q2 2025) per Business Quant data.